MICHELLE RENKO: Open Payments
NPI 1912283250 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 75 payments from 15 companies in 2025. Trend: 2023 $431 · 2024 $965 · 2025 $1,348
Food & beverage: $1,342Education: $7
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $294 |
| ABBVIE INC. | 21 | $269 |
| Regeneron Healthcare Solutions, Inc. | 7 | $234 |
| Galderma Laboratories, L.P. | 7 | $154 |
| UCB, Inc. | 14 | $136 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $31 |
| MIMEDX Group, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
Products named: DUPIXENT, RINVOQ, NEMLUVIO, Bimzelx, SKYRIZI, COSENTYX, Zoryve, TREMFYA.
Industry payments across OH — which companies pay providers there.
